Additionally, single-nucleotide polymorphism survival prognostic analysis showed that specific genetic variants associated with IL-1RA, B-NGF, and M-CSF may influence overall survival (OS) and cancer-specific survival (CSS) in patients with thyroid cancer, further supporting their potential value in thyroid cancer management. This evidence concerns the gene CSF1 and thyroid gland carcinoma.